Deep Learning Model Using Transfer Learning for Detecting Left Ventricular Systolic Dysfunction: Retrospective Algorithm Development and Validation Study
Authors:
Open Access
- 24 April 2026
- journal article
- research article
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 14 (1) , e83127
Abstract
Background: Artificial intelligence–augmented electrocardiogram (AI-ECG) models for detecting left ventricular systolic dysfunction (LVSD) often exhibit degraded performance in patients with comorbidities. Objective: This study aimed to introduce and validate a recalibration method using longitudinal patient data to enhance prediction accuracy and simulate its clinical utility for ongoing monitoring. Methods: We conducted a multicenter, retrospective cohort study using data from 2 hospitals in Korea. A dataset of paired transthoracic echocardiograms (TTEs) and electrocardiograms (ECGs) matched within a 2-week interval was constructed, separating pairs into baseline (first for each patient) and follow-up assessments. In addition to conventional supervised learning, we developed a patient-wise recalibration strategy that incorporated historical left ventricular ejection fraction measurements and prior AI-ECG outputs to adjust for future predictions, thus empirically mitigating confounding effects. Pretraining was also implemented to enhance the model’s performance. Results: The recalibrated 12-lead DeepECG LVSD model achieved an area under the receiver operating curve of 0.956 (95% CI 0.946‐0.965) for internal validation and 0.940 (95% CI 0.936‐0.945) for external validation of follow-up TTE-ECG pairs. The uncalibrated 12-lead DeepECG LVSD model also showed modest performance, with an area under the receiver operating curve of 0.953 (95% CI 0.941‐0.965) in the internal validation and 0.947 (95% CI 0.943‐0.951) in the external validation when tested on baseline TTE-ECG pairs. Recalibration yielded statistically significant improvements in the 12-lead DeepECG LVSD models ( P <.001), with enhanced and more balanced performance across all clinical subgroups. Conclusions: Patient-wise recalibration improved accuracy and consistency across various comorbidities by mitigating performance degradation and bias. This broadens the application of AI-ECG for LVSD detection from low-risk screening to high-risk longitudinal monitoring.Keywords
This publication has 33 references indexed in Scilit:
- Artificial intelligence-enabled electrocardiogram for mortality and cardiovascular risk estimation: a model development and validation studyThe Lancet Digital Health, 2024
- Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trialThe Lancet, 2022
- CardioNet: An Efficient ECG Arrhythmia Classification System Using Transfer LearningBig Data Research, 2021
- Using Deep-Learning Algorithms to Simultaneously Identify Right and Left Ventricular Dysfunction From the ElectrocardiogramJACC: Cardiovascular Imaging, 2021
- Training confounder-free deep learning models for medical applicationsNature Communications, 2020
- Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extensionThe Lancet Digital Health, 2020
- Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extensionThe Lancet Digital Health, 2020
- ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart DiseaseJACC, 2019
- Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart FailureJACC: Heart Failure, 2016
- Index for rating diagnostic testsCancer, 1950